Xenon Pharmaceuticals Inc.
Clinical trials sponsored by Xenon Pharmaceuticals Inc., explained in plain language.
-
New depression drug tested for long-term safety in 460 patients
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety and effectiveness of azetukalner in adults with major depressive disorder who have already completed a previous phase 3 trial. About 460 participants will take the drug as their only treatment and be monitored for side effects and changes …
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated May 26, 2026 07:54 UTC
-
New epilepsy drug shows promise in Long-Term seizure control
Disease control ENROLLING_BY_INVITATIONThis study is testing a medication called XEN1101 to see if it is safe and works well for controlling seizures over a long period—up to 6 years. It includes 880 adults and adolescents with focal or generalized tonic-clonic seizures who have already completed an earlier XEN1101 st…
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New drug shows promise for Long-Term bipolar depression control
Disease control ENROLLING_BY_INVITATIONThis study tests the long-term safety and effectiveness of azetukalner in 400 adults with bipolar I or II depression who already completed a previous study on the same drug. Participants will take the medication openly (everyone knows they are getting it) for an extended period. …
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated May 11, 2026 20:50 UTC